exonbio Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Exonbio is a biotechnology research company specializing in recombinant antibodies and recombinant proteins. It uses SPIN (Single Plasma Cell Interrogation) technology to develop rabbit recombinant monoclonal antibodies, a capability within antibody discovery. Based in San Diego, California, the company operates with a small team. In October 2020, Exonbio announced the launch of SARS-CoV-2 Spike recombinant monoclonal antibodies for antigen assays and COVID-19 therapeutics, highlighting its involvement in infectious disease applications. The products are aimed at researchers and developers seeking high-affinity antibodies for diagnostics and therapeutic development related to SARS-CoV-2.